Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.45
-0.40 (-2.52%)
At close: Aug 10, 2026, 4:00 PM EDT
15.50
+0.05 (0.32%)
After-hours: Aug 10, 2026, 6:35 PM EDT
Aurinia Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 126.57 | 80.21 | 83.43 | 48.88 | 94.17 | 231.9 |
Short-Term Investments | 185.31 | 317.78 | 275.04 | 301.61 | 295.22 | 234.18 |
Cash & Short-Term Investments | 311.89 | 398 | 358.48 | 350.49 | 389.39 | 466.08 |
Cash Growth | -1.03% | 11.03% | 2.28% | -9.99% | -16.45% | 17.01% |
Accounts Receivable | 28.95 | 41.45 | 36.54 | 24.09 | 13.48 | 15.41 |
Inventory | 31.78 | 45.69 | 39.23 | 39.71 | 24.75 | 19.33 |
Other Current Assets | 8.38 | 6.83 | 12.35 | 10.52 | 14.91 | 12.51 |
Total Current Assets | 381 | 491.97 | 446.6 | 424.8 | 442.54 | 513.32 |
Net Property, Plant & Equipment | 48.24 | 79.57 | 98.87 | 116.57 | 8.56 | 9.8 |
Other Intangible Assets | 2.38 | 3.76 | 4.36 | 4.98 | 6.43 | 8.4 |
Long-Term Investments | - | - | - | 0.2 | - | - |
Other Long-Term Assets | 126.01 | 176.29 | 0.82 | 1.52 | 13.34 | 11.84 |
Total Assets | 557.62 | 751.59 | 550.65 | 548.06 | 470.86 | 543.37 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.22 | 3.31 | 5.19 | 4.33 | 39.99 | 34.95 |
Accrued Expenses | 45.12 | 66.62 | 64.97 | 50.06 | - | - |
Current Portion of Leases | 12.8 | 17.59 | 15.07 | 15.6 | 0.94 | 1.06 |
Unearned Revenue | 7.46 | 3.72 | 11 | 4.81 | 3.15 | 0.19 |
Other Current Liabilities | 3.71 | 2.48 | 1.53 | 2.39 | 2.03 | 4.45 |
Total Current Liabilities | 70.31 | 93.72 | 97.76 | 77.19 | 46.11 | 40.65 |
Long-Term Leases | 32.34 | 57.22 | 64.3 | 82.01 | 7.15 | 7.68 |
Other Long-Term Liabilities | 22.21 | 19.31 | 11.11 | 10.91 | 12.17 | 15.95 |
Total Long-Term Liabilities | 54.55 | 76.53 | 75.4 | 92.92 | 19.32 | 23.63 |
Total Liabilities | 124.86 | 170.26 | 173.17 | 170.11 | 65.43 | 64.28 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 786.36 | 1,120 | 1,188 | 1,200 | 1,185 | 1,177 |
Additional Paid-in Capital | 53.63 | 111.26 | 127 | 120.79 | 85.49 | 59.01 |
Accumulated Other Comprehensive Income | -0.69 | -0.6 | -0.65 | -0.73 | -1.06 | -0.85 |
Retained Earnings | -406.54 | -649.37 | -936.57 | -942.32 | -864.3 | -756.12 |
Shareholders' Equity | 432.76 | 581.33 | 377.48 | 377.95 | 405.44 | 479.09 |
Total Liabilities & Equity | 557.62 | 751.59 | 550.65 | 548.06 | 470.86 | 543.37 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 45.14 | 74.81 | 79.37 | 97.61 | 8.09 | 8.74 |
Net Cash (Debt) | 266.74 | 323.19 | 279.11 | 252.88 | 381.3 | 457.34 |
Net Cash Growth | 14.33% | 15.79% | 10.37% | -33.68% | -16.63% | 17.29% |
Net Cash Per Share | 1.95 | 2.33 | 1.91 | 1.76 | 2.69 | 3.54 |
Book Value | 432.76 | 581.33 | 377.48 | 377.95 | 405.44 | 479.09 |
Book Value Per Share | 3.17 | 4.19 | 2.58 | 2.64 | 2.86 | 3.70 |
Tangible Book Value | 430.39 | 577.57 | 373.12 | 372.98 | 399.01 | 470.69 |
Tangible Book Value Per Share | 3.15 | 4.16 | 2.55 | 2.60 | 2.81 | 3.64 |